QZ

Qingdao Zhongtai Huiyin Investment Management Partnership

Asia, Shandong, China, Qingdao Shi

Description

Qingdao Zhongtai Huiyin Investment Management Partnership

Investor Profile

Qingdao Zhongtai Huiyin Investment Management Partnership has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Association
  • Biotechnology
  • Manufacturing
  • Non Profit
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qingdao Zhongtai Huiyin Investment Management Partnership frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Qiandao Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Ligong investment
Asia, Shanghai, China, Putuo
Co-Investments: 1
GF Venture Capital
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Finnova Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Huajin Capital
Asia, Guangdong, China, Zhuhai
Co-Investments: 1
SDIC Venture Capital
Asia, Hebei, China, Xicheng
Co-Investments: 1
Horus Capital
Asia, Shandong, China, Qingdao Shi
Co-Investments: 1

What are some of recent deals done by Qingdao Zhongtai Huiyin Investment Management Partnership?

MabPlex International

Fremont, California, United States

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

AssociationBiotechnologyManufacturingNon Profit
Series BJun 8, 2020
Amount Raised: $70,708,356